Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
02 09 2021
Historique:
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 23 11 2021
Statut: ppublish

Résumé

To investigate the relationship between retinal structure and macular function in eyes screened for hydroxychloroquine (HCQ) toxicity. Participants referred for hydroxychloroquine retinopathy screening with spectral domain optical coherence tomography (SD-OCT) and multifocal electroretinogram (mfERG) testing were included in the analysis. Amplitude and implicit time of mfERG N1 and P1 responses were included in the analysis. Ring ratios were computed for amplitude values as the ratio of rings 1-3:5 (R1-3:R5). A control group of healthy participants was included for comparison of SD-OCT metrics. Sixty-three eyes screened for HCQ retinopathy and 30 control eyes were analyzed. The outer nuclear layer (ONL) was significantly thinner in HCQ patients in the foveal (P = 0.008), parafoveal (P < 0.0001), and perifoveal (P < 0.0001) regions. The HCQ cohort was further divided into two subgroups according to the presence of structural clinically detectable retinopathy (i.e., structural damage as detected by multimodal imaging). HCQ eyes without retinopathy had a thinner ONL thickness in the foveal (P = 0.032), parafoveal (P < 0.0001), and perifoveal (P < 0.0001) regions and a thinner inner nuclear layer (INL) in the parafoveal region (P = 0.045 versus controls). Structural changes in HCQ patients without retinopathy were significantly associated with macular function as R2:R5 ring ratio of mfERG P1 amplitude was associated with INL (P = 0.002) and ONL (P = 0.044) thicknesses, and R3:R5 ring ratio of P1 amplitude was associated with ONL thickness (P = 0.004). Our results suggest that structural alterations secondary to HCQ toxicity may occur in the absence of clinically detectable retinopathy, and this may reflect in an impaired macular function.

Identifiants

pubmed: 34581725
pii: 2777936
doi: 10.1167/iovs.62.12.28
pmc: PMC8479571
doi:

Substances chimiques

Antirheumatic Agents 0
Hydroxychloroquine 4QWG6N8QKH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

28

Références

Clin Exp Ophthalmol. 2007 Jan-Feb;35(1):32-7
pubmed: 17300568
Br J Ophthalmol. 2012 May;96(5):723-9
pubmed: 22328813
Am J Ophthalmol. 2005 Nov;140(5):794-807
pubmed: 16310457
Eye (Lond). 2010 May;24(5):756-62; quiz 763
pubmed: 20395978
Electroencephalogr Clin Neurophysiol. 1987 May;68(3):161-71
pubmed: 2436875
Int J Retina Vitreous. 2016 Jul 18;2:18
pubmed: 27847636
JAMA Ophthalmol. 2014 Sep;132(9):1105-12
pubmed: 24922444
Ophthalmology. 2014 Jun;121(6):1257-62
pubmed: 24439759
Ophthalmology. 2011 Feb;118(2):415-22
pubmed: 21292109
Ophthalmology. 2016 Jun;123(6):1386-94
pubmed: 26992838
Invest Ophthalmol Vis Sci. 1978 Dec;17(12):1158-75
pubmed: 102610
Am J Ophthalmol. 2010 Mar;149(3):496-502.e1
pubmed: 20042179
Invest Ophthalmol Vis Sci. 2002 May;43(5):1673-85
pubmed: 11980890
Retina. 2016 Oct;36(10):1941-50
pubmed: 27258672
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD25-AMD30
pubmed: 29860309
Doc Ophthalmol. 2006 May;112(3):177-87
pubmed: 16804707
Ophthalmology. 2015 Jan;122(1):110-6
pubmed: 25182842
Br J Ophthalmol. 2019 Jan;103(1):3-7
pubmed: 30190364
Int Ophthalmol. 2020 Mar;40(3):571-581
pubmed: 31712927
J Ophthalmol. 2016;2016:8643174
pubmed: 27656292
Br J Ophthalmol. 2019 Nov;103(11):1600-1604
pubmed: 30819690
JAMA Ophthalmol. 2013 Sep;131(9):1187-97
pubmed: 23887202
Prog Retin Eye Res. 2006 Sep;25(5):425-48
pubmed: 16949855
Am J Ophthalmol. 1972 Feb;73(2):229-35
pubmed: 4335678
PLoS One. 2017 May 11;12(5):e0177515
pubmed: 28493982
Ophthalmology. 2015 Jun;122(6):1239-1251.e4
pubmed: 25824328
Br J Ophthalmol. 2003 Jul;87(7):899-901
pubmed: 12812895
Doc Ophthalmol. 2021 Feb;142(1):5-16
pubmed: 33492495
J Refract Surg. 1997 Jul-Aug;13(4):388-91
pubmed: 9268940
Retina. 2019 Mar;39(3):473-484
pubmed: 30741731
Invest Ophthalmol Vis Sci. 2014 Nov 25;56(1):396-402
pubmed: 25425304
Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2133-41
pubmed: 22427567
Invest Ophthalmol Vis Sci. 2011 Oct 28;52(11):8425-32
pubmed: 21948552
Am J Ophthalmol. 2019 Oct;206:132-139
pubmed: 31078540
Acta Ophthalmol. 2018 Mar;96(2):e156-e163
pubmed: 28926202
JAMA Ophthalmol. 2016 May 1;134(5):511-519
pubmed: 26986043
Clin Med Insights Arthritis Musculoskelet Disord. 2013 Aug 08;6:35-43
pubmed: 23997576
Ophthalmology. 2015 Jun;122(6):1252-6
pubmed: 25712474
Ophthalmology. 2021 Jan;128(1):110-119
pubmed: 32553941
Doc Ophthalmol. 2012 Feb;124(1):1-13
pubmed: 22038576
Am J Ophthalmol. 2007 May;143(5):801-809
pubmed: 17336914

Auteurs

Enrico Borrelli (E)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Marco Battista (M)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maria Lucia Cascavilla (ML)

Vita-Salute San Raffaele University Milan, Milan, Italy.

Chiara Viganò (C)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Federico Borghesan (F)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Nicolò Nicolini (N)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lidia Clemente (L)

IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.

Riccardo Sacconi (R)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Costanza Barresi (C)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandro Marchese (A)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elisabetta Miserocchi (E)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giulio Modorati (G)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesco Bandello (F)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giuseppe Querques (G)

Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH